These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 9045317)

  • 1. Tamoxifen and endometrial cancer: tamoxifen effects on the human female genital tract.
    Cohen CJ
    Semin Oncol; 1997 Feb; 24(1 Suppl 1):S1-55-S1-64. PubMed ID: 9045317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tamoxifen and endometrial cancer: tamoxifen effects on the human female genital tract.
    Jordan VC
    J Womens Health; 1997 Aug; 6(4):486-7. PubMed ID: 9279837
    [No Abstract]   [Full Text] [Related]  

  • 3. The nature of tamoxifen action in the control of female breast cancer.
    Kodama M; Kodama T
    In Vivo; 2001; 15(4):319-25. PubMed ID: 11695224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [MR Imaging of the pelvis in the diagnosis of the endometrium in breast cancer patients in tamoxifen therapy].
    Hauth E; Libera H; Kimmig R; Forsting M
    Rofo; 2006 Mar; 178(3):316-23. PubMed ID: 16508840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison between the effects of tamoxifen and toremifene on the uterus in postmenopausal breast cancer patients.
    Tomás E; Kauppila A; Blanco G; Apaja-Sarkkinen M; Laatikainen T
    Gynecol Oncol; 1995 Nov; 59(2):261-6. PubMed ID: 7590484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of endometrial changes among symptomatic tamoxifen-treated and nontreated premenopausal and postmenopausal breast cancer patients.
    Cheng WF; Lin HH; Torng PL; Huang SC
    Gynecol Oncol; 1997 Aug; 66(2):233-7. PubMed ID: 9264568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The incidence of subsequent endometrial carcinoma with tamoxifen use in patients with primary breast carcinoma.
    Katase K; Sugiyama Y; Hasumi K; Yoshimoto M; Kasumi F
    Cancer; 1998 May; 82(9):1698-703. PubMed ID: 9576291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Monitoring women on tamoxifen ].
    Lansac J; Diouf A
    J Gynecol Obstet Biol Reprod (Paris); 1998 Apr; 27(3):285-9. PubMed ID: 9648006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of tamoxifen on the female genital tract.
    Senkus-Konefka E; Konefka T; Jassem J
    Cancer Treat Rev; 2004 May; 30(3):291-301. PubMed ID: 15059652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tamoxifen regulates human telomerase reverse transcriptase (hTERT) gene expression differently in breast and endometrial cancer cells.
    Wang Z; Kyo S; Maida Y; Takakura M; Tanaka M; Yatabe N; Kanaya T; Nakamura M; Koike K; Hisamoto K; Ohmichi M; Inoue M
    Oncogene; 2002 May; 21(22):3517-24. PubMed ID: 12032853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective study on gynaecological effects of two antioestrogens tamoxifen and toremifene in postmenopausal women.
    Marttunen MB; Cacciatore B; Hietanen P; Pyrhönen S; Tiitinen A; Wahlström T; Ylikorkala O
    Br J Cancer; 2001 Apr; 84(7):897-902. PubMed ID: 11286468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of endometrial cancer in asymptomatic postmenopausal breast cancer patient treated with tamoxifen: a case report.
    Sinawat S; Chiyabutra T; Kleabkaew P
    J Med Assoc Thai; 2001 Jul; 84(7):1033-6. PubMed ID: 11759963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma.
    Nola M; Jukić S; Ilić-Forko J; Babić D; Uzarević B; Petrovecki M; Suchanek E; Skrablin S; Dotlić S; Marusić M
    Gynecol Oncol; 1999 Mar; 72(3):331-6. PubMed ID: 10053103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen and progesterone receptors in the endometrium of postmenopausal breast cancer patients treated with tamoxifen and progestogens.
    Cohen I; Altaras MM; Beyth Y; Shapira J; Figer A; Tepper R; Cordoba M; Yigal D; Bernheim J
    Gynecol Oncol; 1997 Apr; 65(1):83-8. PubMed ID: 9103396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effects of tamoxifen on the female genital tract].
    Mourits MJ; van der Zee AG; Willemse PH; Hollema H; de Vries EG
    Ned Tijdschr Geneeskd; 2003 Nov; 147(47):2315-20. PubMed ID: 14669536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rationale for sequential tamoxifen and anticancer drugs in adjuvant setting for patients with node- and receptor-positive breast cancer.
    Kim R; Tanabe K; Emi M; Uchida Y; Osaki A; Toge T
    Int J Oncol; 2005 Apr; 26(4):1025-31. PubMed ID: 15753998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overview of studies on endometrial cancer and other types of cancer in humans: perspectives of an epidemiologist.
    MacMahon B
    Semin Oncol; 1997 Feb; 24(1 Suppl 1):S1-122-S1-39. PubMed ID: 9045310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a new clinically relevant antiestrogen (GW5638) related to tamoxifen on breast and endometrial cancer growth in vivo.
    Dardes RC; O'Regan RM; Gajdos C; Robinson SP; Bentrem D; De Los Reyes A; Jordan VC
    Clin Cancer Res; 2002 Jun; 8(6):1995-2001. PubMed ID: 12060645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tamoxifen and endometrial pathologies: a prospective study.
    Seoud M; Shamseddine A; Khalil A; Salem Z; Saghir N; Bikhazi K; Bitar N; Azar G; Kaspar H
    Gynecol Oncol; 1999 Oct; 75(1):15-9. PubMed ID: 10502419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of raloxifene and tamoxifen on the expression of estrogen receptors and antigen Ki-67 in human endometrial adenocarcinoma cell line.
    Koda M; Jarzabek K; Haczynski J; Knapp P; Sulkowski S; Wolczynski S
    Oncol Rep; 2004 Sep; 12(3):517-21. PubMed ID: 15289830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.